Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development

N Engl J Med. 1974 Dec 12;291(24):1268-71. doi: 10.1056/NEJM197412122912402.
No abstract available

MeSH terms

  • Abnormalities, Drug-Induced / etiology*
  • Aluminum / adverse effects
  • Anxiety / drug therapy
  • Child, Preschool
  • Chlordiazepoxide / adverse effects*
  • Chlordiazepoxide / therapeutic use
  • Embryo, Mammalian / drug effects*
  • Female
  • Fetal Death / chemically induced
  • Fetus / drug effects*
  • Glutethimide / adverse effects
  • Humans
  • Hydrochlorothiazide / adverse effects
  • Hydroxides / adverse effects
  • Infant
  • Infant, Newborn
  • Magnesium / adverse effects
  • Meprobamate / adverse effects*
  • Meprobamate / therapeutic use
  • Methamphetamine / adverse effects
  • Pentobarbital / adverse effects
  • Phenobarbital / adverse effects
  • Piperazines / adverse effects
  • Pregnancy
  • Pregnancy Complications / drug therapy
  • Pregnancy Trimester, First
  • Prospective Studies
  • Vitamins / adverse effects

Substances

  • Hydroxides
  • Piperazines
  • Vitamins
  • Hydrochlorothiazide
  • Methamphetamine
  • Chlordiazepoxide
  • Meprobamate
  • Glutethimide
  • Aluminum
  • Magnesium
  • Pentobarbital
  • Phenobarbital